| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.021 | 0.7 |